VE-cadherin and PECAM-1 enhance ALL migration across brain microvascular endothelial cell monolayers

Experimental Hematology

Volumn 38, Issue 9, 2010, Pages 733-743

  Akers, Stephen M ^a   O'Leary, Heather A ^a   Minnear, Fred L ^a   Craig, Michael D ^a   Vos, Jeffrey A ^a   Coad, James E ^a   Gibson, Laura F ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; VASCULAR ENDOTHELIAL CADHERIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD BRAIN BARRIER; CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DISRUPTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR DYNAMICS; PHENOTYPE; PHILADELPHIA CHROMOSOME POSITIVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 77955518345     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.05.001     Document Type: Article

References (35)

1. Pui C.H., Evans W.E. Acute lymphoblastic leukemia. N Engl J Med 1998, 339:605-615.
2. Pui C.H. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematology Am Soc Hematol Educ Program 2006, 142-146.
3. Lazarus H.M., Richards S.M., Chopra R., et al. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993. Blood 2006, 108:465-472.
4. Cortes J. Central nervous system involvement in adult acute lymphocytic leukemia. Hematol Oncol Clin North Am 2001, 15:145-162.
5. Butler R.W., Haser J.K. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev 2006, 12:184-191.
6. Cole P.D., Kamen B.A. Delayed neurotoxicity associated with therapy for children with acute lymphoblastic leukemia. Ment Retard Dev Disabil Res Rev 2006, 12:174-183.
7. Ransohoff R.M., Kivisakk P., Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 2003, 3:569-581.
8. Engelhardt B., Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 2005, 26:485-495.
9. Bazzoni G., Dejana E. Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 2004, 84:869-901.
10. Vorbrodt A.W., Dobrogowska D.H. Molecular anatomy of interendothelial junctions in human blood-brain barrier microvessels. Folia Histochem Cytobiol 2004, 42:67-75.
11. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
12. Hickey W.F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol 1991, 1:97-105.
13. Wang L., O'Leary H., Fortney J., Gibson L.F. Ph+/VE-cadherin+ identifies a stem cell like population of acute lymphoblastic leukemia sustained by bone marrow niche cells. Blood 2007, 110:3334-3344.
14. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
15. Xu M., Waters C.L., Hu C., Wysolmerski R.B., Vincent P.A., Minnear F.L. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase. Am J Physiol Cell Physiol 2007, 293:C1309-C1318.
16. Alter A., Duddy M., Hebert S., et al. Determinants of human B cell migration across brain endothelial cells. J Immunol 2003, 170:4497-4505.
17. Man S., Ubogu E.E., Williams K.A., Tucky B., Callahan M.K., Ransohoff R.M. Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration. Clin Dev Immunol 2008, 2008. 384982.
18. Li B., Zhao W.D., Tan Z.M., Fang W.G., Zhu L., Chen Y.H. Involvement of Rho/ROCK signalling in small cell lung cancer migration through human brain microvascular endothelial cells. FEBS Lett 2006, 580:4252-4260.
19. Weksler B.B., Subileau E.A., Perriere N., et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 2005, 19:1872-1874.
20. Law I.P., Blom J. Adult acute leukemia: frequency of central system involvement in long term survivors. Cancer 1977, 40:1304-1306.
21. Pfeifer H., Wassmann B., Hofmann W.K., et al. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. Clin Cancer Res 2003, 9:4674-4681.
22. Kim I., Yilmaz O.H., Morrison S.J. CD144 (VE-cadherin) is transiently expressed by fetal liver hematopoietic stem cells. Blood 2005, 106:903-905.
23. Baumann C.I., Bailey A.S., Li W., Ferkowicz M.J., Yoder M.C., Fleming W.H. PECAM-1 is expressed on hematopoietic stem cells throughout ontogeny and identifies a population of erythroid progenitors. Blood 2004, 104:1010-1016.
24. Jackson D.E., Gully L.M., Henshall T.L., Mardell C.E., Macardle P.J. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is associated with a naive B-cell phenotype in human tonsils. Tissue Antigens 2000, 56:105-116.
25. Zhou Y., Fisher S.J., Janatpour M., et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?. J Clin Invest 1997, 99:2139-2151.
26. Bulla R., Villa A., Bossi F., et al. VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. Exp Cell Res 2005, 303:101-113.
27. Hendrix M.J., Seftor E.A., Hess A.R., Seftor R.E. Molecular plasticity of human melanoma cells. Oncogene 2003, 22:3070-3075.
28. Labelle M., Schnittler H.J., Aust D.E., et al. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling. Cancer Res 2008, 68:1388-1397.
29. Marchetti D., Denkins Y., Reiland J., et al. Brain-metastatic melanoma: a neurotrophic perspective. Pathol Oncol Res 2003, 9:147-158.
30. Rustin G.J., Newlands E.S., Begent R.H., Dent J., Bagshawe K.D. Weekly alternating etoposide, methotrexate, and actinomycin/vincristine and cyclophosphamide chemotherapy for the treatment of CNS metastases of choriocarcinoma. J Clin Oncol 1989, 7:900-903.
31. Aroca F., Renaud W., Bartoli C., Bouvier-Labit C., Figarella-Branger D. Expression of PECAM-1/CD31 isoforms in human brain gliomas. J Neurooncol 1999, 43:19-25.
32. Tang D.G., Chen Y.Q., Newman P.J., et al. Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J Biol Chem 1993, 268:22883-22894.
33. Rijcken E., Mennigen R.B., Schaefer S.D., et al. PECAM-1 (CD 31) mediates transendothelial leukocyte migration in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007, 293:G446-G452.
34. Duncan G.S., Andrew D.P., Takimoto H., et al. Genetic evidence for functional redundancy of Platelet/Endothelial cell adhesion molecule-1 (PECAM-1): CD31-deficient mice reveal PECAM-1-dependent and PECAM-1-independent functions. J Immunol 1999, 162:3022-3030.
35. Muller W.A., Weigl S.A., Deng X., Phillips D.M. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993, 178:449-460.